We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Clinical-Grade Human Pluripotent Stem Cells for Cell Therapy: Characterization Strategy.
- Authors
Rehakova, Daniela; Souralova, Tereza; Koutna, Irena
- Abstract
Human pluripotent stem cells have the potential to change the way in which human diseases are cured. Clinical-grade human embryonic stem cells and human induced pluripotent stem cells have to be created according to current good manufacturing practices and regulations. Quality and safety must be of the highest importance when humans' lives are at stake. With the rising number of clinical trials, there is a need for a consensus on hPSCs characterization. Here, we summarize mandatory and ′for information only′ characterization methods with release criteria for the establishment of clinical-grade hPSC lines.
- Subjects
HUMAN stem cells; INDUCED pluripotent stem cells; HUMAN embryonic stem cells; STEM cell treatment; EMBRYONIC stem cells; CURRENT good manufacturing practices; PLURIPOTENT stem cells
- Publication
International Journal of Molecular Sciences, 2020, Vol 21, Issue 7, p2435
- ISSN
1661-6596
- Publication type
Article
- DOI
10.3390/ijms21072435